Similar articles

• Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator.

  Sharma K, Ziyadeh FN. Sharma K, et al. Diabetes. 1995 Oct;44(10):1139-46. doi: 10.2337/diab.44.10.1139. Diabetes. 1995. PMID: 7556948 Review.
• High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.

  Qi W, Chen X, Zhang Y, Holian J, Mreich E, Gilbert RE, Kelly DJ, Pollock CA. Qi W, et al. Nephrol Dial Transplant. 2007 Nov;22(11):3147-53. doi: 10.1093/ndt/gfm365. Epub 2007 Jul 29. Nephrol Dial Transplant. 2007. PMID: 17664181
• Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.

  Russo LM, del Re E, Brown D, Lin HY. Russo LM, et al. Diabetes. 2007 Feb;56(2):380-8. doi: 10.2337/db06-1018. Diabetes. 2007. PMID: 17259382
• Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.

  Dai C, Yang J, Bastacky S, Xia J, Li Y, Liu Y. Dai C, et al. J Am Soc Nephrol. 2004 Oct;15(10):2637-47. doi: 10.1097/01.ASN.0000139479.09658.EE. J Am Soc Nephrol. 2004. PMID: 15466268
• Role of TGF-beta in pathogenesis of diabetic nephropathy.

  Pantsulaia T. Pantsulaia T. Georgian Med News. 2006 Feb;(131):13-8. Georgian Med News. 2006. PMID: 16575121 Review.